Cargando…

Immune Responses to HBV Vaccine in People Living with HIV (PLWHs) Who Achieved Successful Treatment: A Prospective Cohort Study

Background: Understanding immune responses after HBV vaccination is important to prevent HBV infection in PLWH and to achieve successful treatment. Methods: Thirty-two PLWHs with CD4(+) cell count > 350 cells/µL and HIV RNA < 200 copies/mL were vaccinated with 20 µg of HBV vaccine at weeks 0,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Ling, Zhang, Li, Kang, Shuang, Li, Xiaodi, Lu, Lianfeng, Liu, Xiaosheng, Song, Xiaojing, Li, Yanling, Li, Xiaoxia, Lyu, Wei, Cao, Wei, Liu, Zhengyin, Li, Taisheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967144/ https://www.ncbi.nlm.nih.gov/pubmed/36851279 http://dx.doi.org/10.3390/vaccines11020400

Ejemplares similares

HBV pgRNA profiles in Chinese HIV/HBV coinfected patients under pre‐ and posttreatment: a multicentre observational cohort study
por: Xu, Ling, et al.
Publicado: (2022)

CD4(+) T cell counts and soluble programmed death-1 at baseline correlated with hepatitis B surface antigen decline in HIV/HBV coinfection during combined antiretroviral therapy
por: Li, Xiaodi, et al.
Publicado: (2023)

Comparison of Renal Function Biomarkers of Serum Creatinine and Cystatin C in HIV-Infected People on Dolutegravir-Containing Therapy
por: Lu, Lianfeng, et al.
Publicado: (2022)

Comparative Transcriptional Analysis Identified Characteristic Genes and Patterns in HIV-Infected Immunological Non-Responders
por: Liu, Xiaosheng, et al.
Publicado: (2022)

The pattern and magnitude of T cell subsets reconstitution during ten years of ART with viral suppression in HIV-infected patients
por: Lu, Lianfeng, et al.
Publicado: (2022)

Safety and efficacy of long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection: a systematic review and meta-analysis protocol
por: Wu, Yuan-ni, et al.
Publicado: (2022)

Benefits of high-dose intravenous immunoglobulin on mortality in patients with severe COVID-19: An updated systematic review and meta-analysis
por: Liu, Xiaosheng, et al.
Publicado: (2023)

Altered plasma metabolites and inflammatory networks in HIV-1 infected patients with different immunological responses after long-term antiretroviral therapy
por: Lu, Lianfeng, et al.
Publicado: (2023)

Immunological changes after COVID-19 vaccination in an HIV-positive patient
por: Gong, Changlin, et al.
Publicado: (2022)

Prolonged presence of viral nucleic acid in clinically recovered COVID-19 patients was not associated with effective infectiousness
por: Hong, Ke, et al.
Publicado: (2020)

High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects
por: Liu, Xiaosheng, et al.
Publicado: (2020)

Corrigendum: High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China
por: Cao, Wei, et al.
Publicado: (2021)

High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China
por: Cao, Wei, et al.
Publicado: (2021)

Incidence of hypertension among persons living with HIV in China: a multicenter cohort study
por: Fan, Hongwei, et al.
Publicado: (2020)

Hypothesis for potential pathogenesis of SARS-CoV-2 infection–a review of immune changes in patients with viral pneumonia
por: Lin, Ling, et al.
Publicado: (2020)

Emergence of Lamivudine-Resistant HBV during Antiretroviral Therapy Including Lamivudine for Patients Coinfected with HIV and HBV in China
por: Gu, Lijun, et al.
Publicado: (2015)

Risk factors and longitudinal changes of dyslipidemia among Chinese people living with HIV receiving antiretroviral therapy
por: Li, Xiuxia, et al.
Publicado: (2023)

(5R)-5-hydroxytriptolide for HIV immunological non-responders receiving ART: a randomized, double-blinded, placebo-controlled phase II study
por: Cao, Wei, et al.
Publicado: (2023)

Renal Involvement and HBV Infection Are Common in Chinese Patients With Cryoglobulinemia
por: Bai, Wei, et al.
Publicado: (2021)

Naïve CD4(+) cell counts significantly decay and high HIV RNA levels contribute to immunological progression in long-term non-progressors infected with HIV by blood products: a cohort study
por: Xu, Ling, et al.
Publicado: (2021)

Cardiovascular disease risk among Chinese antiretroviral-naïve adults with advanced HIV disease
por: Guo, Fuping, et al.
Publicado: (2017)

Optimizing Treatment for Adults with HIV/AIDS in China: Successes over Two Decades and Remaining Challenges
por: Cao, Wei, et al.
Publicado: (2020)

Closing the gap to achieve HBV elimination by 2030: A global pursuit fueled by regional successes
por: Wong, Robert J.
Publicado: (2021)

Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients
por: Zhang, Yan, et al.
Publicado: (2020)

Quantitative HBsAg versus HBV DNA in Predicting Significant Hepatitis Activity of HBeAg-Positive Chronic HBV Infection
por: Zhang, Zhanqing, et al.
Publicado: (2021)

The decline of HBV RNA associated with HBeAg seroconversion and double-negative HBV DNA and RNA in chronic hepatitis B patients who received entecavir therapy: a 10-year retrospective cohort study
por: Ye, Feng, et al.
Publicado: (2022)

Therapeutic prediction of HIV-1 DNA decay: a multicenter longitudinal cohort study
por: Yue, Yongsong, et al.
Publicado: (2021)

Week 120 Efficacy of Tenofovir, Lamivudine and Lopinavir/r-Based Second-Line Antiretroviral Therapy in Treatment-Experienced HIV Patients
por: Han, Yang, et al.
Publicado: (2015)

HIV-1 CRF01_AE subtype and HIV-1 DNA level among patients with chronic HIV-1 infection: a correlation study
por: Lyu, Tingxia, et al.
Publicado: (2020)

Immunological alterations after immunotherapy with short lived HBV‐TCR T cells associates with long‐term treatment response in HBV‐HCC
por: Tan, Anthony Tanoto, et al.
Publicado: (2021)

Investigation of healthy living strategies in elderly who achieved to live long and healthy
por: Sahinoz, Turgut, et al.
Publicado: (2020)

Correction to: Pharmacodynamics of efavirenz 400 mg in treatment-naïve Chinese HIV-infected patients in a prospective cohort study
por: Xu, Ling, et al.
Publicado: (2021)

Pharmacodynamics of efavirenz 400 mg in treatment-naïve Chinese HIV-infected patients in a prospective cohort study
por: Xu, Ling, et al.
Publicado: (2021)

Antiviral therapy inhibited HBV-reactivation and improved long-term outcomes in patients who underwent radiofrequency ablation for HBV-related hepatocellular carcinoma
por: Liu, Jian, et al.
Publicado: (2023)

A lipid metabolism–based prognostic risk model for HBV–related hepatocellular carcinoma
por: Zhou, Lili, et al.
Publicado: (2023)

Remember who you are: achieve success create balance experience fulfillment
por: Stafford, Paula Brown, et al.
Publicado: (2018)

May early intervention with intravenous immunoglobulin pose a potentially successful treatment for Ebola virus infection?
por: Ge, Ying, et al.
Publicado: (2014)

Host immunity and HBV S gene mutation in HBsAg-negative HBV-infected patients
por: Liu, Xin, et al.
Publicado: (2023)

Prevalence of hepatitis B and C viruses in HIV-positive patients in China: a cross-sectional study
por: Xie, Jing, et al.
Publicado: (2016)

Exosomes Modulate the Viral Replication and Host Immune Responses in HBV Infection
por: Li, Shuang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2on705jla4gakj8qhkqh4h515o